This information is intended for US healthcare professionals to access current scientific information about Janssen products. It is prepared by Janssen Medical Information and is not intended for promotional purposes, nor to provide medical advice.

STELARA and Adalimumab in Crohn’s Disease - SEAVUE Study

Last Updated: 04/25/2023


A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link: